First Episealer® Talus surgery planned in Norway

Report this content

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Norway with the ankle implant Episealer® Talus has been scheduled. Since previously, the Episealer® Knee technology is available in Norway.

“We are now offering the Episealer® Talus technology to our Norwegian customers, and we are pleased with having the first surgery in Norway scheduled. Episurf’s Episealer® implants for the knee joint have been used in Norway for some time”, says Pål Ryfors, CEO Episurf Medical.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: